Recombinant Human Cell surface glycoprotein MUC18 (MCAM)

What is the molecular structure of MCAM/MUC18/CD146?

MCAM is a type I transmembrane glycoprotein (~113 kDa) belonging to the immunoglobulin superfamily (IgSF). Its structure consists of a 536 amino acid extracellular domain (ECD), a 24 amino acid transmembrane domain, and a 63 amino acid cytoplasmic domain. Two splice variants exist, differing in cytoplasmic tail length. The ECD contains 2 IgV and 3 IgC2 domains, sharing 74% and 73% sequence identity with mouse and rat homologs, respectively . When designing experiments to study MCAM structure, researchers should consider domain-specific antibodies or truncated constructs to determine which regions mediate specific functions.

What are the primary cellular functions of MCAM?

MCAM functions as a cellular adhesion molecule (CAM) that mediates intercellular interactions between homotypic or heterotypic cells and facilitates cell-extracellular matrix interactions in response to physiological signals . It plays crucial roles in multiple cellular processes including adhesion, migration, proliferation, and differentiation . Additionally, MCAM is implicated in recruiting activated T cells to inflammatory sites and is upregulated in various inflammatory diseases . When studying MCAM function, experimental designs should incorporate multiple readouts (adhesion assays, migration assays, proliferation measurements) to capture its diverse roles.

How is MCAM expression regulated in normal tissues versus pathological conditions?

MCAM was originally identified as a marker of malignant potential in melanoma, but its expression has since been detected in endothelial cells throughout the body . In pathological conditions, particularly cancer, MCAM expression levels correlate directly with tumor progression and metastatic potential . Methodologically, researchers should employ quantitative techniques (qPCR, Western blot, flow cytometry) to measure expression levels across various tissues and disease states, while controlling for tissue-specific factors that might influence expression.

What experimental approaches best elucidate MCAM's role in metastasis?

To investigate MCAM's role in metastasis, researchers should employ multi-faceted approaches combining in vitro and in vivo methodologies. In vitro studies should include invasion assays, migration assays, and 3D culture systems to assess cellular behavior. For in vivo studies, xenograft models with MCAM-expressing versus MCAM-knockout cells can reveal metastatic potential differences. Antibody neutralization studies, such as those using the fully human anti-MUC18 antibody ABX-MA1, can assess the effects of MCAM blockade on metastasis in animal models . Researchers should specifically measure effects on tumor growth, adhesion, invasion, and metastatic colonization to different organs.

How do post-translational modifications affect MCAM function in different tissue contexts?

This advanced question requires detailed glycoproteomic analyses. MCAM is heavily glycosylated, which may influence its binding properties and signaling capabilities. Experimental approaches should include:

• Site-directed mutagenesis of potential glycosylation sites

• Treatment with glycosidases to remove specific modifications

• Mass spectrometry analysis of tissue-specific glycoforms

• Functional assays comparing differentially modified MCAM variants

Data interpretation should account for heterogeneity in glycosylation patterns between tissue types and pathological states.

What are the molecular mechanisms of MCAM-mediated signal transduction?

MCAM signaling investigation requires careful experimental design using phosphoproteomics, protein-protein interaction studies, and pathway analysis. Researchers should:

• Identify MCAM binding partners through co-immunoprecipitation and mass spectrometry

• Map phosphorylation events following MCAM activation using phospho-specific antibodies

• Use specific pathway inhibitors to determine signaling dependencies

• Employ CRISPR/Cas9 to generate cytoplasmic domain mutants affecting potential signaling motifs

A methodological challenge is distinguishing direct MCAM signaling from indirect effects mediated through associated proteins.

How does MCAM contribute to tumor progression in different cancer types?

MCAM has been implicated in multiple cancer types, originally in melanoma but also in bone sarcomas . Research approaches should include comparative analysis of MCAM expression and function across cancer types, correlating expression with clinical outcomes and metastatic potential. Studies have demonstrated that MCAM plays a central role in the metastasis of osteosarcoma, suggesting targeted inhibition through antibodies like ABX-MA1 might be effective therapeutic strategies . Experimental designs should address tissue-specific mechanisms, as MCAM may function differently depending on the cancer microenvironment.

What is the relationship between MCAM and inflammatory disease progression?

MCAM has been implicated in recruiting activated T cells to inflammatory sites and is upregulated in various inflammatory diseases . Research methodologies should include:

• Flow cytometry analysis of MCAM+ immune cell populations in inflammatory conditions

• Intravital microscopy to track MCAM-mediated cell recruitment in real-time

• Selective blocking experiments using anti-MCAM antibodies in models of inflammatory disease

• Analysis of soluble MCAM as a potential biomarker of inflammation

These approaches can help determine whether MCAM inhibition represents a viable therapeutic approach for conditions like inflammatory bowel disease .

How does the MCAM-Galectin-3 interaction influence endothelial function in vascular diseases?

Recent research has identified MCAM as the functional ligand for Galectin-3 on endothelial cell surfaces, responsible for circulating galectin-3-mediated endothelial secretion of cytokines . To study this interaction, researchers should:

• Perform binding assays with recombinant proteins to characterize interaction kinetics

• Use surface plasmon resonance to measure binding affinities

• Employ knockout models of either protein to assess functional consequences

• Analyze cytokine profiles following stimulation or inhibition of this pathway

This interaction may represent a novel therapeutic target in vascular inflammatory conditions.

What are optimal protocols for producing functional recombinant MCAM for research applications?

Production of functional recombinant MCAM requires careful consideration of expression systems and purification strategies. Recommended approaches include:

The extracellular domain (ECD) of human MCAM contains 5 immunoglobulin-like domains, with 2 IgV and 3 IgC2 types . For functional studies, researchers should consider FC-chimera constructs that maintain proper folding while facilitating purification and detection.

What considerations are important when designing MCAM knockout or knockdown experiments?

When designing genetic manipulation experiments for MCAM, researchers should consider:

• Complete knockout versus conditional systems (tissue-specific or inducible)

• Potential compensatory mechanisms by related adhesion molecules

• Developmental effects that might confound adult phenotypes

• Off-target effects, particularly with siRNA approaches

For CRISPR/Cas9 knockout designs, multiple guide RNAs targeting different exons should be compared, with careful validation by sequencing, protein expression analysis, and phenotypic rescue experiments.

How can researcher's optimize antibody-based detection of MCAM in different experimental contexts?

Antibody selection is critical for MCAM research, with different applications requiring specific considerations:

Researchers should verify antibody specificity using multiple approaches and consider epitope accessibility in native versus denatured states.

How can apparent contradictions in MCAM functional studies be reconciled?

Contradictory findings in MCAM research often stem from context-dependent functions. Methodological approaches to resolve these include:

• Systematic comparison of experimental conditions (cell types, culture conditions, assay timing)

• Meta-analysis of published data with attention to methodological differences

• Collaboration between labs to reproduce findings using standardized protocols

• Multi-parameter analysis to capture complex phenotypes

When analyzing contradictory data, researchers should consider that MCAM may have differential effects depending on cell type, microenvironment, and interaction partners.

What statistical approaches are most appropriate for analyzing MCAM expression data in heterogeneous tissue samples?

Heterogeneous tissue samples present analytical challenges for MCAM expression studies. Recommended statistical approaches include:

• Multiple Correspondence Analysis (MCA) for categorical variable analysis, which can reveal non-linear effects that Principal Component Analysis might miss

• Clustering algorithms to identify subpopulations with distinct expression patterns

• Mixed-effects models to account for within-sample and between-sample variability

• Bayesian approaches for integrating prior knowledge with new experimental data

Researchers should avoid simple averaging across heterogeneous samples, as this may obscure biologically relevant subpopulations.

How should researchers interpret correlations between MCAM expression and disease progression?

When interpreting correlations between MCAM expression and disease outcomes, researchers should:

• Distinguish between correlation and causation through mechanistic studies

• Control for confounding variables (tumor stage, treatment history, patient demographics)

• Perform multivariate analysis rather than focusing on univariate correlations

• Validate findings across independent cohorts using consistent measurement techniques

Longitudinal studies with repeated measurements can provide stronger evidence for MCAM's role in disease progression than single-timepoint correlations.

What emerging technologies might advance MCAM research in the next decade?

Emerging technologies with potential to transform MCAM research include:

• Single-cell multi-omics for understanding MCAM's role in heterogeneous cell populations

• CRISPR screening to identify new interacting partners and regulatory pathways

• Advanced imaging techniques like super-resolution microscopy to visualize MCAM clustering and interactions at the membrane

• Organ-on-chip technologies to study MCAM in complex multicellular environments

These technologies will allow more sophisticated experimental designs that capture MCAM's context-dependent functions.

What are promising therapeutic strategies targeting MCAM that warrant further investigation?

Building on existing research, several therapeutic approaches targeting MCAM show promise:

• Monoclonal antibodies like ABX-MA1 for blocking MCAM function in cancer

• Small molecule inhibitors of MCAM-mediated interactions

• Targeted delivery of cytotoxic agents using MCAM-binding molecules

• CAR-T cell approaches directed against MCAM-expressing tumors

Experimental design for these therapeutic approaches should include rigorous target validation, pharmacodynamic biomarkers, and appropriate in vivo models that recapitulate human disease.

How might systems biology approaches enhance our understanding of MCAM's role in cellular networks?

Systems biology offers powerful frameworks for understanding MCAM within broader cellular networks. Recommended approaches include:

• Network analysis to identify key nodes that interact with MCAM

• Mathematical modeling of MCAM-dependent signaling pathways

• Integration of multiple data types (transcriptomic, proteomic, metabolomic)

• Experimental design principles that account for big data analysis requirements

These approaches can help identify emergent properties of MCAM-mediated cellular behaviors that might not be apparent from reductionist studies.